logo

SANOFI vs WOCKPHARMA: Stock Comparison

SANOFI INDIA vs WOCKHARDTUpdated 22 Oct 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. SANOFI INDIA shows a lower P/E, a higher ROE and a higher dividend yield, while WOCKHARDT shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SANOFI leads 9; WOCKPHARMA leads 2 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SANOFIWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹6,529 Cr
₹30,126 Cr
P/E RatioSANOFI has the lower reading
0x ✓
73.66x
P/B RatioSANOFI has the lower reading
0x ✓
6.1x
EPSSANOFI has the higher reading
₹39.64 ✓
₹6.52
Book ValueContext only
₹325.31
₹325
Dividend YieldSANOFI has the higher reading
4.36% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹30,126 Cr vs ₹6,529 Cr
P/E Ratio
SANOFI has a lower P/E
0x vs 73.66x
P/B Ratio
SANOFI has a lower P/B
0x vs 6.1x
EPS
SANOFI has higher earnings per share
₹39.64 vs ₹6.52
Dividend Yield
SANOFI has a higher dividend yield
4.36% vs 0%
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs -11.9%
EPS Growth (TTM YoY)
WOCKPHARMA has faster EPS growth
0% vs -14.1%
ROE
SANOFI has a higher ROE
41.35% vs 3.77%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSANOFIWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSANOFIWOCKPHARMA
Live Price₹2,831.1₹1,855.5
Day Change0.13%-1.16%
Volume15,2774.57 L
52-Week High₹4,898₹2,422.3
52-Week Low₹2,820.1₹1,086.7
Distance from 52W High-42.2%-23.4%

Valuation

MetricSANOFIWOCKPHARMA
Market Cap₹6,529 Cr₹30,126 Cr
P/E Ratio0x73.66x
P/B Ratio0x6.1x
EPS₹39.64₹6.52
Book Value₹325.31₹325
Dividend Yield4.36%0%

Growth

MetricSANOFIWOCKPHARMA
Revenue Growth (TTM YoY)-11.9%26%
EPS Growth (TTM YoY)-14.1%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricSANOFIWOCKPHARMA
ROE41.35%3.77%
ROCE64.11%5.44%
Net Margin19.26%3.3%
Operating Margin23.62%13.37%
Debt to Equity0x0.4x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSANOFIWOCKPHARMA
Promoter Holding0%49.08%
FII Holding5.69%▲ 0.05 pp7.22%▲ 0.13 pp
DII Holding19.87%▼ 1.26 pp9.24%▼ 1.72 pp
Public Holding14.04%▲ 1.21 pp34.44%▲ 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SANOFI INDIA and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.